Last update 01 Nov 2024

Moderna Biotech Spain, S.L.

Spain

Overview

Tags

Respiratory Diseases
Other Diseases
Infectious Diseases
Prophylactic vaccine
mRNA vaccine

Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
Disease DomainCount
Infectious Diseases2
Immune System Diseases1
Top 5 Drug TypeCount
mRNA vaccine2
Prophylactic vaccine2
Top 5 TargetCount
SARS-CoV-2 S protein1
RSV F protein(Respiratory syncytial virus F protein)1

Related

2
Drugs associated with Moderna Biotech Spain, S.L.
Respiratory Syncytial Virus Vaccine(Moderna)
Target
RSV F protein
Mechanism
Respiratory syncytial virus F protein modulators
Active Org.
ModernaTX, Inc. [+2]
Originator Org.
Moderna, Inc.Moderna, Inc.
Active Indication
Pneumonia due to respiratory syncytial virus [+5]
Inactive Indication-
Drug Highest PhaseApproved
First Approval Ctry. / Loc.
US
First Approval Date31 May 2024
Elasomeran
Target
SARS-CoV-2 S protein
Mechanism
SARS-CoV-2 S protein inhibitors
Active Org.
Moderna, Inc.Moderna, Inc. [+4]
Originator Org.
Moderna, Inc.Moderna, Inc.
Active Indication
COVID-19 omicron variant infection [+6]
Inactive Indication-
Drug Highest PhaseApproved
First Approval Ctry. / Loc.
CA
First Approval Date23 Dec 2020
100 Clinical Results associated with Moderna Biotech Spain, S.L.
Login to view more data
0 Patents (Medical) associated with Moderna Biotech Spain, S.L.
Login to view more data
100 Deals associated with Moderna Biotech Spain, S.L.
Login to view more data
100 Translational Medicine associated with Moderna Biotech Spain, S.L.
Login to view more data

Corporation Tree

Boost your research with our corporation tree data.
login
or
view full example data
Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 08 Nov 2024

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Approved
2
Login to view more data

Current Projects

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Profit

Explore the financial positions of over 360K organizations with Synapse.
login
or
view full example data
Explore the financial positions of over 360K organizations with Synapse.

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.
login
or
view full example data
Access more than 2 million grant and funding information to elevate your research journey.

Investment

Gain insights on the latest company investments from start-ups to established corporations.
login
or
view full example data
Gain insights on the latest company investments from start-ups to established corporations.

Financing

Unearth financing trends to validate and advance investment opportunities.
login
or
view full example data
Unearth financing trends to validate and advance investment opportunities.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free